COPD复健.ppt

Pulmonary Rehabilitation Dynamic Hyperinflation Effect of Bronchodilators on Hyperinflation Domiciliary Positive Expiratory Pressure Improves Pulmonary Function and Exercise Capacity in Patients with Chronic Obstructive Pulmonary Disease Pulmonary Rehabilitation for Respiratory Muscle Impairment Diaphragm training Lower lobes volume recruitment Pulmonary RehabilitationMucus Clearance Negative Pressure Ventilation Positive Pressure Ventilation Factors Contributing to Skeletal Muscle Wasting in COPD TNF-? and Cachexia in Chronic Airway Diseases Heart Rate Variability (HRV) for Autonomic Dysfunction Heart Rate Variability (HRV) for Autonomic Dysfunction Pulmonary Rehabilitation for Quadriceps Muscle Impairment Limbs/trunk Exercise Electrical Stimulation 6-Minute Walking Test (Assessment) Effect of Long-term Pulmonary Rehabilitation on Walking Distance Shuttle walking test Incremental Shuttle Walking Test The Availability of Coverage for Long-term Home Oxygen Treatment under Medicare Community Pulmonary Rehabilitation after Hospitalisation for Acute Exacerbations of COPDRandomised Controlled Study Lower parasympathetic activity at rest Relative higher parasympathetic activity during exercise Low frequency (LF) - Sympathetic Parasympathetic activity High frequency (HF) - Parasympathetic activity ANS imbalance VLF ? Leptin, AMPK ? Cachexia Skeletal muscle dsyfunction Resting HF ? Exercise HF ? Resting Heart Rate ? Exercise LF ? Bronchoconstriction Mucus secretion Pulmonary perfusion ? V/Q mismatch O2 consumption Pulmonary rehabilitation Exercise limitation Very low frequency (VLF) – Neuroendocrine and Thermoregulatory influences Low frequency (LF) - Sympathetic Parasympathetic activity High frequency (HF) - Parasympathetic activity Autonomic Dysfunction 0.98 ? 1.05? 1.72 ? 2.77 0.83 ? 1.01? 1.77 ? 2.33 3.67 ? 3.63? 1.06 ? 0.81 LF/HF (nu)* 61.17 ? 157.60 72.26 ? 87.89 12.71 ? 15.53#? 76.15 ? 96.19 108.10 ? 124.00 72.84 ? 46.14 VLF (nu)* 20.29